KRT19 and breast cancer: Using a quantitative RT-PCR for detecting CK-19 mRNA-positive cells, we observed a concordance rate of 93.9 and 72.6% between peripheral blood and bone marrow samples obtained before initiation and after completion of adjuvant chemotherapy, respectively, in patients with early breast cancer.